Sanofi's Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-i ...
The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.
County health officials identify access, fitness and chronic disease prevention as priorities as demand grows for physician-led wellness, weight and aesthetic services.
Opinion
14don MSNOpinion
'Can't defend this, I'm out!': Tucker Carlson breaks up with GOP over party's 'Israel first' agenda
Conservative commentator Tucker Carlson has announced a dramatic break with the Republican Party, declaring that there is 'no chance' he will support the GOP in the upcoming midterm elections.
As scientists gain a deeper understanding of how the body’s immune system remembers pathogens it must fight, the paradigm for ...
First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insu ...
KFF Health News on MSN
Autism’s new territory: From camel’s milk and stem cell injections to spelling therapy
Autism’s new territory: From camel’s milk and stem cell injections to spelling therapy Elizabeth Bonker is a silent woman ...
News, recaps, highlights and winners from the Tokyo Paralympic Games on the night of Thursday, August 26 and morning of ...
The global long-acting drugs market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and ...
MedinCell SA () has held its Q4 earnings call. Read on for the main highlights of the call. TipRanks' Prime Week Sale - 70% Off. Unlock powerful investing tools and data-driven in ...
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...
ORIGIN 3 randomized 431 biopsy‑confirmed IgAN patients 1:1; atacicept 150 mg weekly SC produced the largest placebo‑adjusted UPCR reduction reported at week 36. Accelerated approval hinged on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results